Gps Wealth Strategies Group, LLC Xeris Biopharma Holdings, Inc. Transaction History
Gps Wealth Strategies Group, LLC
- $881 Million
- Q3 2025
A detailed history of Gps Wealth Strategies Group, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 65,089 shares of XERS stock, worth $471,895. This represents 0.06% of its overall portfolio holdings.
Number of Shares
65,089
Previous 64,925
0.25%
Holding current value
$471,895
Previous $303,000
73.93%
% of portfolio
0.06%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding XERS
# of Institutions
239Shares Held
94.3MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...